Evidence map›Paper›PMID 32532853›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2020

Cell-Based No-Wash Fluorescence Assays for Compound Screens Using a Fluorescence Cytometry Plate Reader.

Kirill Gorshkov, Manisha Pradhan, Miao Xu, Shu Yang, Emily M Lee, Catherine Z Chen, Min Shen, Wei Zheng

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kirill GorshkovNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland kirill.gorshkov@nih.gov.ORCID 0000-0002-4652-8818
Manisha PradhanNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Miao XuNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Shu YangNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Emily M LeeNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Catherine Z ChenNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Min ShenNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland.
Wei ZhengNational Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland wzheng@mail.nih.gov.ORCID 0000-0003-1034-0757
National Institutes of Health · US

Funding

Drug Repurposing Screening for Rare and Neglected DiseasesZIATR000018 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI ZHENG, WEI · 2015 to 2025
$24.6M
6 · The paper itself

Abstract

High-throughput cell-based fluorescent imaging assays often require removal of background fluorescent signal to obtain robust measurements. Processing high-density microplates to remove background signal is challenging because of equipment requirements and increasing variation after multiple plate wash steps. Here, we present the development of a wash-free cell-based fluorescence assay method for high-throughput screening using a laser scanning fluorescence plate cytometer. The cytometry data consisted of cell count and fluorescent intensity measurements for phenotypic screening. We obtained robust screening results by applying this assay methodology to the lysosomal storage disease Niemann-Pick disease type A. We further demonstrated that this cytometry method can be applied to the detection of cholesterol in Niemann-Pick disease type C. Lastly, we used the Mirrorball method to obtain preliminary results for the detection of Zika and Dengue viral envelope protein. The advantages of this assay format include 1) no plate washing, 2) 4-fold faster plate scan and analysis time, 3) high throughput, and 4) >10-fold smaller direct data files. In contrast, traditional imaging assays require multiple plate washes to remove the background signal, long plate scan and data analysis times, and large data files. Therefore, this versatile and broadly applicable Mirrorball-based method greatly improves the throughput and data quality of image-based screening by increasing sensitivity and efficiency while reducing assay artifacts. SIGNIFICANCE STATEMENT: This work has resulted in the development of broadly applicable cell-based fluorescence imaging assays without the requirement of washing out reagents to reduce background signal, which effectively decreases the need for extensive plate processing by the researcher. We demonstrate this high-throughput method for drug screening against lysosomal storage diseases and a commonly used viral titer assay.

Indexed as

Biological AssayCells, CulturedDengueDengue VirusDrug Evaluation, PreclinicalFluorescenceHigh-Throughput Screening AssaysHumansViral Envelope ProteinsZika VirusZika Virus InfectionViral Envelope Proteins

Identifiers

PMID32532853
PMCPMC7495342
OpenAlexW3035734571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.